Disclosed herein is a stable amorphous co-precipitate of rotigotine with pharmaceutically acceptable excipients, method for the preparation, pharmaceutical compositions, and method of treating thereof. Advantageously, the amorphous co-precipitates of rotigotine of the present invention have improved physiochemical characteristics that assist in the effective bioavailability.